Advocacy at a Glance 9/29/17 Advocacy at a Glance 9/29/17 Advocacy at a Glance Read More Advocacy at a Glance 9/22/17 Advocacy at a Glance 9/22/17 Where We're at Now and What's Coming Next Read More Advocacy at a Glance 9/22/17 Advocacy at a Glance 9/22/17 Advocacy at a Glance Read More Advocacy at a Glance 9/15/17 Advocacy at a Glance 9/15/17 Where to Stash the 18,000 Bodies: a Master Plan Read More Advocacy at a Glance 9/15/17 Advocacy at a Glance 9/15/17 Advocacy at a Glance Read More Analysis and Commentary 9/8/17 Analysis and Commentary 9/8/17 Some Shocks -- Some Pleasant; Some Less So Read More Advocacy at a Glance 9/8/17 Advocacy at a Glance 9/8/17 Advocacy at a Glance Read More Advocacy at a Glance 9/1/17 Advocacy at a Glance 9/1/17 A "Breather", a Summary Review, and a Re-commitment Read More Advocacy at a Glance 9/1/17 Advocacy at a Glance 9/1/17 Advocacy at a Glance Read More Advocacy at a Glance 8/20/17 Advocacy at a Glance 8/20/17 All Aboard for the FY 18 Rollercoaster Ride Read More Advocacy at a Glance 8/20/17 Advocacy at a Glance 8/20/17 Advocacy at a Glance Read More Analysis and Commentary 8/11/17 Analysis and Commentary 8/11/17 It's Going to Get Tougher From Here Read More Advocacy at a Glance 8/11/17 Advocacy at a Glance 8/11/17 Advocacy at a Glance Read More Analysis and Commentary 8/4/17 Analysis and Commentary 8/4/17 The FDA Budget FY 18: Where Does the Money Come From? Read More Advocacy at a Glance 8/4/17 Advocacy at a Glance 8/4/17 Advocacy at a Glance Read More Analysis and Commentary 7/27/17 Analysis and Commentary 7/27/17 Challenges and Threats to FDA Resources: An Update Read More Advocacy at a Glance 7/27/17 Advocacy at a Glance 7/27/17 Advocacy at a Glance Read More Analysis and Commentary 7/21/17 Analysis and Commentary 7/21/17 Level Funding for FY 18 Will NOT Allow FDA to Meet All Current Needs Read More Advocacy at a Glance 7/21/17 Advocacy at a Glance 7/21/17 Advocacy at a Glance Read More Advocacy at a Glance 7/14/17 Advocacy at a Glance 7/14/17 More Good Progress; Still No Certainties Read More Newer Posts Older Posts
Advocacy at a Glance 9/22/17 Advocacy at a Glance 9/22/17 Where We're at Now and What's Coming Next Read More
Advocacy at a Glance 9/15/17 Advocacy at a Glance 9/15/17 Where to Stash the 18,000 Bodies: a Master Plan Read More
Analysis and Commentary 9/8/17 Analysis and Commentary 9/8/17 Some Shocks -- Some Pleasant; Some Less So Read More
Advocacy at a Glance 9/1/17 Advocacy at a Glance 9/1/17 A "Breather", a Summary Review, and a Re-commitment Read More
Advocacy at a Glance 8/20/17 Advocacy at a Glance 8/20/17 All Aboard for the FY 18 Rollercoaster Ride Read More
Analysis and Commentary 8/11/17 Analysis and Commentary 8/11/17 It's Going to Get Tougher From Here Read More
Analysis and Commentary 8/4/17 Analysis and Commentary 8/4/17 The FDA Budget FY 18: Where Does the Money Come From? Read More
Analysis and Commentary 7/27/17 Analysis and Commentary 7/27/17 Challenges and Threats to FDA Resources: An Update Read More
Analysis and Commentary 7/21/17 Analysis and Commentary 7/21/17 Level Funding for FY 18 Will NOT Allow FDA to Meet All Current Needs Read More
Advocacy at a Glance 7/14/17 Advocacy at a Glance 7/14/17 More Good Progress; Still No Certainties Read More
